Binary-blend fibber-based capture assay of circulating tumor cells for clinical diagnosis of colorectal cancer by Ai-Wei Lee, Fu-Xiang Lin, Po-Li Wei, Guo Jian-Wei, Jem-Kun Chen

Subjects: Get full text

Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases by Stefano Guadagni, Francesco Masedu, Giammaria Fiorentini, Donatella Sarti, Caterina Fiorentini, Veronica Guadagni, Panagiotis Apostolou, Ioannis Papasotiriou, Panagiotis Parsonidis, Marco Valenti, Enrico Ricevuto, Gemma Bruera, Antonietta R. Farina, Andrew R. Mackay, Marco Clementi

Get full text

The Role of Circulating Biomarkers in Lung Cancer by Sayuri Herath, Habib Sadeghi Rad, Payar Radfar, Rahul Ladwa, Majid Warkiani, Ken O’Byrne, Ken O’Byrne, Arutha Kulasinghe

Subjects: “…Circulating tumour cells…”
Get full text

Liquid Biopsy in Small Cell Lung Cancer—A Route to Improved Clinical Care? by Matt Church, Louise Carter, Fiona Blackhall

Subjects: Get full text

Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options by Sugan Panneerselvam, Cornelia Wilson, Prem Kumar, Dinu Abirami, Jayakrishna Pamarthi, Mettu Srinivas Reddy, Joy Varghese

Subjects: “…Circulating tumour cell…”
Get full text

A FACS-based novel isolation technique identifies heterogeneous CTCs in oral squamous cell carcinoma by Anshika Chauhan, Arnab Pal, Meenakshi Sachdeva, Geeta S. Boora, Monil Parsana, Jaimanti Bakshi, Roshan Kumar Verma, Radhika Srinivasan, Debajyoti Chatterjee, Arindam Maitra, Sushmita Ghoshal

Subjects: “…circulating tumour cells…”
Get full text

Single‐cell and spatial omics unravel the spatiotemporal biology of tumour border invasion and haematogenous metastasis by Xifu Cheng, Yuke Cao, Xiangyi Liu, Yuanheng Li, Qing Li, Dian Gao, Qiongfang Yu

Subjects: “…circulating tumour cell…”
Get full text

Effectiveness of peritoneal lavage fluid circulating tumour cells and circulating tumour DNA in the prediction of metachronous peritoneal metastasis of gastric cancer (pT4NxM0/pT1-3N+M0) after radical resection: protocol of a prospective single-centre clinical study by Long Bai, Jiayi Gu, Yujing Guan, Yeqian Zhang, Bo Ni, Hao-yu Zhang, Muerzhate Aimaiti, Shuchang Wang, Ben Yue, Xiang Xia, Zizhen Zhang

“…The primary objective of this study is to observe and evaluate the predictive effect of intraoperative peritoneal lavage fluid (PLF) circulating tumour cells (CTC) and circulating tumour DNA (ctDNA) levels in patients with pT4NxM0/pT1-3N+M0 GC on metachronous PM after R0 resection.Methods and analysis This prospective single-centre clinical study is conducted at Renji Hospital, Shanghai Jiao Tong University School of Medicine. …”
Get full text

Treatment Opportunities for Colorectal Liver Metastases by Tormod Lund

Subjects: Get full text

Recent advances in minimally invasive biomarkers of OSCC: from generalized to personalized approach by Smriti Suri, Geeta S. Boora, Rajandeep Kaur, Anshika Chauhan, Sushmita Ghoshal, Arnab Pal

Subjects: Get full text

A Promising Future for Prostate Cancer Diagnostics by Stephen J. Assinder, Vanitha Bhoopalan

Subjects: Get full text

Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability by Sarah A. Jeffreys, Branka Powter, Bavanthi Balakrishnar, Kelly Mok, Patsy Soon, André Franken, Hans Neubauer, Paul de Souza, Therese M. Becker

Get full text

Fourier Transform Infrared microspectroscopy identifies single cancer cells in blood. A feasibility study towards liquid biopsy by Lewis M. Dowling, Paul Roach, Eirik A. Magnussen, Achim Kohler, Srinivas Pillai, Daniel G. van Pittius, Ibraheem Yousef, Josep Sulé-Suso

“…Identifying circulating tumour cells in blood allows a better assessment for tumour screening, staging, response to treatment and follow up. …”
Get full text

Fourier Transform Infrared microspectroscopy identifies single cancer cells in blood. A feasibility study towards liquid biopsy. by Lewis M Dowling, Paul Roach, Eirik A Magnussen, Achim Kohler, Srinivas Pillai, Daniel G van Pittius, Ibraheem Yousef, Josep Sulé-Suso

“…Identifying circulating tumour cells in blood allows a better assessment for tumour screening, staging, response to treatment and follow up. …”
Get full text

Tumour travel tours – Why circulating cancer cells value company by Sophia Julia Häfner

“…Welcome to the New Year and a new issue of the Biomedical Journal, where we learn that travelling with company boosts the metastatic potential of circulating tumour cells, as well as that a worm could be an excellent model to study antidiabetic drugs. …”
Get full text

Coherent anti-Stokes Raman scattering imaging of lipids in cancer metastasis by Cheng Ji-Xin, Huff Terry B, Le Thuc T

“…Most importantly, the revelation of lipid-rich circulating tumour cells suggests possible development of CARS intravital flow cytometry for label-free detection of early-stage cancer metastasis.…”
Get full text

Unifying metastasis--Integrating intravasation, circulation and end organ colonization by Scott, J, Kuhn, P, Anderson, A

“…Recent technological advances that have enabled the measurement of circulating tumour cells (CTCs) in patients have spurred interest in the circulatory phase of metastasis. …”

Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells by Tanzila Khan, John G. Lock, Yafeng Ma, David G. Harman, Paul de Souza, Wei Chua, Bavanthi Balakrishnar, Kieran F. Scott, Therese M. Becker

“…Its detectability in circulating tumour cells (CTCs) opens non-invasive diagnostic avenues. …”
Get full text

Year of Expanding into Circulating Biomarkers by Shidong Jia, Winston Patrick Kuo

“…More emphasis is placed on fostering engagement with academic and industry sources operating at the cutting-edge of translational technologies applied to the field of circulating biomarkers (interface between extracellular vesicles including exosomes and microvesicles, circulating tumour cells, cell-free circulating DNA and circulating protein markers) and with those in the investment arena seeking and providing private funding for this area of research.…”
Get full text

Opportunities and challenges of circulating biomarkers in neuroblastoma by Ricky M. Trigg, Jacqui A. Shaw, Suzanne D. Turner

“…Over the past decade, there has been growing interest in the utility of circulating biomarkers such as cell-free nucleic acids, circulating tumour cells and extracellular vesicles as a so-called liquid biopsy of cancer. …”
Get full text